| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |